- Home
- ZYME vs TWO Comparison
ZYME vs TWO Comparison
Compare ZYME & TWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- TWO
- Stock Information
- Founded
- ZYME 2003
- TWO 2009
- Country
- ZYME United States
- TWO United States
- Employees
- ZYME N/A
- TWO N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- TWO Real Estate Investment Trusts
- Sector
- ZYME Health Care
- TWO Real Estate
- Exchange
- ZYME Nasdaq
- TWO Nasdaq
- Market Cap
- ZYME 1.2B
- TWO 1.1B
- IPO Year
- ZYME 2017
- TWO 2009
- Fundamental
- Price
- ZYME $16.56
- TWO $9.66
- Analyst Decision
- ZYME Buy
- TWO Buy
- Analyst Count
- ZYME 7
- TWO 8
- Target Price
- ZYME $20.00
- TWO $12.50
- AVG Volume (30 Days)
- ZYME 648.0K
- TWO 1.9M
- Earning Date
- ZYME 10-30-2025
- TWO 10-27-2025
- Dividend Yield
- ZYME N/A
- TWO 16.18%
- EPS Growth
- ZYME N/A
- TWO N/A
- EPS
- ZYME N/A
- TWO N/A
- Revenue
- ZYME $122,867,000.00
- TWO $257,735,000.00
- Revenue This Year
- ZYME $107.76
- TWO N/A
- Revenue Next Year
- ZYME $2.35
- TWO N/A
- P/E Ratio
- ZYME N/A
- TWO N/A
- Revenue Growth
- ZYME 95.94
- TWO N/A
- 52 Week Low
- ZYME $9.03
- TWO $9.50
- 52 Week High
- ZYME $17.70
- TWO $14.28
- Technical
- Relative Strength Index (RSI)
- ZYME 57.31
- TWO 42.15
- Support Level
- ZYME $16.75
- TWO $9.60
- Resistance Level
- ZYME $17.40
- TWO $10.22
- Average True Range (ATR)
- ZYME 0.58
- TWO 0.17
- MACD
- ZYME -0.06
- TWO -0.02
- Stochastic Oscillator
- ZYME 38.20
- TWO 9.68
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About TWO Two Harbors Investment Corp
Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.